Clinical Trial Update: KW-3357 Study in Patients With Early Onset Severe Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 trial update for KW-3357 in early onset severe preeclampsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• KW-3357

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED